IDSA GUIDELINES Bundle (free trial)

Influenza

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/244261

Contents of this Issue

Navigation

Page 7 of 13

Selecting a Treatment Regimen Table 4. Influenza Vaccines – United States, 2013–2014 Influenza Seasona Trade Name Manufacturer Presentation Inactivated Influenza Vaccine, Trivalent (IIV3), Standard Dose Afluria® CSL Limited Fluarix® GlaxoSmithKline 0.5-mL single-dose prefilled syringe Flucelvax® Novartis Vaccines and Diagnostics 0.5-mL single-dose prefilled syringe FluLaval ® ID Biomedical Corporation of Quebec 5.0-mL multidose vial (distributed by GlaxoSmithKline) Fluvirin® Novartis Vaccines and Diagnostics Fluzone® Sanofi Pasteur 0.5-mL single-dose prefilled syringe 5.0-mL multidose vial 0.5-mL single-dose prefilled syringe 5.0-mL multidose vial 0.25-mL single-dose prefilled syringe 0.5-mL single-dose prefilled syringe 0.5-mL single-dose vial 5.0-mL multidose vial Fluzone Intradermal f Sanofi Pasteur 0.1-mL prefilled microinjection system Inactivated Influenza Vaccine, Trivalent (IIV3), High Dose Fluzone HighDoseh Sanofi Pasteur 0.5-mL single-dose prefilled syringe Inactivated Influenza Vaccine, Quadrivalent (IIV4), Standard Dose Fluarix Quadrivalent GlaxoSmithKline FluLaval Quadrivalent ID Biomedical Corporation of Quebec 5.0-mL multidose vial (distributed by GlaxoSmithKline) Fluzone Quadrivalent Sanofi Pasteur 0.5-mL single-dose prefilled syringe 0.25-mL single-dose prefilled syringe 0.5-mL single-dose prefilled syringe 0.5-mL single-dose vial Recombinant Influenza Vaccine, Trivalent (RIV3) Flublok® Protein Sciences 0.5-mL single-dose vial Live Attenuated Influenza Vaccine, Quadrivalent (LAIV4) FluMist® Quadrivalenti MedImmune 0.2-mL single-dose prefilled intranasal sprayer Package inserts (PIs) for US-licensed vaccines are available at http://www.fda.gov/ BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm093833.htm. Age indication per PI is ≥6 months; however, ACIP recommends that Afluria not be used in children ages 6 months through 8 years because of increased risk for febrile reactions. c For adults and older children, the recommended site of vaccination is the deltoid muscle. The preferred site for infants and young children is the anterolateral aspect of the thigh. d Information not included in PI. The total egg protein is estimated to be <50 femtograms (5 × 10–14 grams) total egg protein (of which a fraction is ovalbumin) per 0.5-mL dose of Flucelvax. e Available on request from Sanofi Pasteur; telephone 1.800.822.2463 or e-mail MIS.Emails@ sanofipasteur.com. a b 6

Articles in this issue

Links on this page

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Influenza